{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ginsenoside Re", "mechanisms", "network pharmacology", "pharmacological effects", "targets"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35617888", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "06", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "13"}], "Language": ["eng"], "ELocationID": ["10.1016/j.phymed.2022.154119", "S0944-7113(22)00197-0"], "Journal": {"ISSN": "1618-095X", "JournalIssue": {"Volume": "102", "PubDate": {"Year": "2022", "Month": "Jul", "Day": "20"}}, "Title": "Phytomedicine : international journal of phytotherapy and phytopharmacology", "ISOAbbreviation": "Phytomedicine"}, "ArticleTitle": "A comprehensive system review of pharmacological effects and relative mechanisms of Ginsenoside Re: Recent advances and future perspectives.", "Pagination": {"StartPage": "154119", "MedlinePgn": "154119"}, "Abstract": {"AbstractText": ["Ginsenoside Re (Re) belongs to protopanaxatriol saponins and exists in Panax ginseng, Panax quinquefolium, Panax notoginseng, and other plants in the Araliaceae family. Re has recently become a research focus owing to its pharmacological activities and benefits to human bodies.", "To summarize recent findings regarding the pharmacological effects and mechanisms of Re and highlight and predict the potential therapeutic effects and systematic mechanism of Re.", "Recent studies (2011-2021) on the pharmacological effects and mechanisms of Re were retrieved from Web of Science, PubMed, Google Scholar, Scopus, and Embase up to December 2021 using relevant keywords. Network pharmacology and bioinformatics analysis were used to predict the therapeutic effects and mechanisms of Re against potential diseases.", "Re presented a wide range of therapeutic and biological activities, including neuroprotective, cardiovascular, antidepressant, antitumorigenic, and others effects. The related pharmacological mechanisms of Re include the regulation of cholinergic and antioxidant systems in the brain; the induction of tumor cell apoptosis; the inhibition of tau protein hyperphosphorylation and oxidative stress; the activation of p38MAPK, ERK1/2, and JNK signals; the improvement of lipid metabolism; and the reduction of endothelial cell dysfunction.", "This paper summarizes comprehensively the current research progress of Re and provides new research insights into the therapeutic effects and mechanisms of Re against potential diseases."], "CopyrightInformation": "Copyright \u00a9 2022 Elsevier GmbH. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China."}], "LastName": "Cai", "ForeName": "Jiasong", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China."}], "LastName": "Huang", "ForeName": "Kunlong", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China."}], "LastName": "Han", "ForeName": "Shengnan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China."}], "LastName": "Chen", "ForeName": "Ruichan", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Chemistry Experiment, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China."}], "LastName": "Li", "ForeName": "Zhijun", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China."}], "LastName": "Chen", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China."}], "LastName": "Chen", "ForeName": "Bing", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China. Electronic address: lsg941@sina.com."}], "LastName": "Li", "ForeName": "Shaoguang", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China."}], "LastName": "Xinhua", "ForeName": "Lin", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China; Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fujian Medical University, Fuzhou, 350122, China; Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, 350122, China. Electronic address: yauhung@126.com."}], "LastName": "Yao", "ForeName": "Hong", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Phytomedicine", "NlmUniqueID": "9438794", "ISSNLinking": "0944-7113"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "46F3R0BL3I", "NameOfSubstance": "ginsenoside Re"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Ginsenosides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Panax"}, {"QualifierName": [], "DescriptorName": "Panax notoginseng"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Saponins"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2022", "Month": "1", "Day": "20"}, {"Year": "2022", "Month": "4", "Day": "3"}, {"Year": "2022", "Month": "4", "Day": "17"}, {"Year": "2022", "Month": "5", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "26", "Hour": "18", "Minute": "25"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35617888", "10.1016/j.phymed.2022.154119", "S0944-7113(22)00197-0"]}}], "PubmedBookArticle": []}